Oxandrolone
- Generic Name
- Oxandrolone
- Brand Names
- Oxandrin
- Drug Type
- Small Molecule
- Chemical Formula
- C19H30O3
- CAS Number
- 53-39-4
- Unique Ingredient Identifier
- 7H6TM3CT4L
- Background
A synthetic hormone with anabolic and androgenic properties.
- Indication
Use to promote weight gain after weight loss following extensive surgery.
- Associated Conditions
- Amino acid catabolism disorder, Pain
- Associated Therapies
- Weight Gain
Oxandrolone Multiligament Knee
- Conditions
- Interventions
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- George F. Hatch
- Target Recruit Count
- 60
- Registration Number
- NCT05893069
- Locations
- 🇺🇸
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
Placebo Versus Oxandrolone Supplementation in Trauma
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Registration Number
- NCT05516849
Use of Oxandrolone to Promote Growth in Infants With HLHS
- Conditions
- Interventions
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Carelon Research
- Target Recruit Count
- 34
- Registration Number
- NCT04090697
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸Children's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Oxandrolone in Healthy Adults: A Relative Bioavailability Study
- First Posted Date
- 2017-07-14
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 6
- Registration Number
- NCT03218631
- Locations
- 🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States
Oxandrolone Rotator Cuff Trial
- Conditions
- Interventions
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 116
- Registration Number
- NCT03091075
- Locations
- 🇺🇸
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone
- Conditions
- Interventions
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Denver Health and Hospital Authority
- Registration Number
- NCT02047552
- Locations
- 🇺🇸
Denver Health Medical Center, Denver, Colorado, United States
Pilot Study of the Safety and Efficacy of Oxandrolone in the Prevention and Treatment of Malnutrition in Infants
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 20
- Registration Number
- NCT01048632
- Locations
- 🇺🇸
Primary Childrens Hospital, Salt Lake City, Utah, United States
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
- Conditions
- Interventions
- Procedure: Stable Isotope Infusion StudyProcedure: Collection of blood and tissuesDrug: HumatropeDrug: KetoconazoleDrug: Oxandrolone and propranolol combinedDrug: PlaceboDrug: Humatrope and propranolol combinedBehavioral: Exercise--Hospital supervised intensive exercise programBehavioral: Home exercise programDrug: OxandroloneDrug: Propranolol
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2019-11-29
- Target Recruit Count
- 1126
- Registration Number
- NCT00675714
- Locations
- 🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
Assessment of Mechanisms of Improved Wound Healing
- Conditions
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2023-07-03
- Target Recruit Count
- 644
- Registration Number
- NCT00673309
- Locations
- 🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00652886
- Locations
- 🇺🇸
Gateway Medical Research, Inc, St.Charles, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.